Proceedings of the PSK Conference (대한약학회:학술대회논문집)
- 2003.04a
- /
- Pages.313.1-313.1
- /
- 2003
Drug-drug interaction with DA-125 and the other anticancer drugs
- Park, Kyung-Jin (Research Laboratories, Dong-A Pharmaceutical Co. Ltd) ;
- Yoon, Hea-Sun (Research Laboratories, Dong-A Pharmaceutical Co. Lt) ;
- Jang, Ji-Myun (Research Laboratories, Dong-A Pharmaceutical Co. Lt) ;
- Shim, Hyun-Joo (Research Laboratories, Dong-A Pharmaceutical Co. Lt) ;
- Kim, Soon-Hoe (Research Laboratories, Dong-A Pharmaceutical Co. Lt) ;
- Kim, Won-Bae (Research Laboratories, Dong-A Pharmaceutical Co. Ltd)
- Published : 2003.04.01
Abstract
DA-125, a novel anthracycline analog containing fluorine with decreased cardiotoxicity and increased antitumor activity of adriamycin (ADM), developed by Research Laboratories of Dong-A Pharmaceutical. DA-125, water soluble prodrug of M1, is a
Keywords